Select topic…AllAbout NRASApni Jung info for South Asian communityCOVID-19Diagnosis and MonitoringDiet and ExerciseEventsFamily PlanningHealthcare professionalsOther ConditionsResearchSelf-managementSymptoms and CausesTreatmentWork and BenefitsSort byNewest – OldestOldest – Newest News, 08 Feb NRAS, partners with Inmedix to develop ‘Stress Matters’ resources The National Rheumatoid Arthritis Society (NRAS) proudly announces that thanks to funding provided by Inmedix, the charity is embarking on a project to develop resources explaining the impact of stress on developing or exacerbating rheumatoid arthritis symptoms. The project will include a UK nationwide survey of those living with rheumatoid arthritis (RA) leading to the […] News, 01 Feb Website Privacy Policy Update We just wanted to make sure our RA and JIA communities are aware that we have updated our Privacy Policy on the 1st February 2022. NRAS is committed to ensuring any data on people who access our services, our supporters or Members, is managed carefully and that the data is fully protected. This policy relates […] News, 06 Dec News from NICE on anti-fibrotic treatment for non-IPF patients NRAS and NICE are pleased to announce that our recent campaign, backed by patients, families and medical experts, to end the inhumane restrictions on a life-extending anti-fibrotic drug for patients with pulmonary fibrosis has been successful. As of 18 October 2021, NICE has agreed that UK doctors will soon be able to prescribe the anti-fibrotic […] News, 02 Dec Ending the Shielding Programme The decision to end shielding At the start of the COVID-19 pandemic, shielding was introduced as one of the few ways to support those who, at the time, were considered clinically extremely vulnerable (CEV). It was the right decision at the time, but we know that shielding advice is extremely restrictive and can have a significant […] News, 17 Sep National Charity launches first of its kind e-learning programme in Rheumatoid Arthritis – SMILE-RA Today, 17 September, 2021, the National Rheumatoid Arthritis Society launches a unique new resource to add to its portfolio of supported self-management programmes, services, publications and digital offerings, called SMILE-RA (Self-Management Individualised Learning Environment in Rheumatoid Arthritis). Rheumatoid Arthritis (>400,000 adults live with RA in the UK) is a serious and complex autoimmune disease characterised […] News, 31 Aug The OCTAVE study results The OCTAVE study results were released on 24 August 2021 and we realise that the initial headlines could cause concern and worry. The study looked at vaccine response of those who are ‘immuno-compromised’ which includes a very wide range of people at varying levels of immune-compression. What the study has shown is that compared to people […] News, 27 Jul HCP Only – GRA physician registry: COVID-19 cases after vaccination If you are a healthcare provider Global Rheumatology Alliance physician registry are looking for patient clinical information on patients with COVID-19 after vaccination. The GRA physician registry is now focusing on patients who develop COVID-19 after their vaccination. If you have these patients, GRA would deeply appreciate if you could take a moment to enter their […] News, 14 Jul Biggest change to treatment of RA since the introduction of biologics in the early 2000s Last month we brought you the news about the Draft Final decision from NICE regarding treatment of ‘moderate active’ RA with some advanced therapies and we’re now delighted to say that as of 14th July this is now Final Guidance. This is an incredible achievement after years of campaigning and has the potential to improve […] News, 05 Jul NRAS launch the #DoThe20Challenge to celebrate 20 years This challenge has now closed. Thank you to everyone who participated and helped raise funds! To celebrate our 20th Anniversary, we have launched #DoThe20Challenge, a fun way supporters can celebrate with us! There are a lot of ideas to get you started, anything that involves the number 20 – are you ready to take on the challenge? […] News, 21 Jan NICE offers hope for thousands who until now, potentially faced a life of disability and pain The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected by […] Previous Page 1 … 6 7 8 9 10 Next Page
News, 08 Feb NRAS, partners with Inmedix to develop ‘Stress Matters’ resources The National Rheumatoid Arthritis Society (NRAS) proudly announces that thanks to funding provided by Inmedix, the charity is embarking on a project to develop resources explaining the impact of stress on developing or exacerbating rheumatoid arthritis symptoms. The project will include a UK nationwide survey of those living with rheumatoid arthritis (RA) leading to the […]
News, 01 Feb Website Privacy Policy Update We just wanted to make sure our RA and JIA communities are aware that we have updated our Privacy Policy on the 1st February 2022. NRAS is committed to ensuring any data on people who access our services, our supporters or Members, is managed carefully and that the data is fully protected. This policy relates […]
News, 06 Dec News from NICE on anti-fibrotic treatment for non-IPF patients NRAS and NICE are pleased to announce that our recent campaign, backed by patients, families and medical experts, to end the inhumane restrictions on a life-extending anti-fibrotic drug for patients with pulmonary fibrosis has been successful. As of 18 October 2021, NICE has agreed that UK doctors will soon be able to prescribe the anti-fibrotic […]
News, 02 Dec Ending the Shielding Programme The decision to end shielding At the start of the COVID-19 pandemic, shielding was introduced as one of the few ways to support those who, at the time, were considered clinically extremely vulnerable (CEV). It was the right decision at the time, but we know that shielding advice is extremely restrictive and can have a significant […]
News, 17 Sep National Charity launches first of its kind e-learning programme in Rheumatoid Arthritis – SMILE-RA Today, 17 September, 2021, the National Rheumatoid Arthritis Society launches a unique new resource to add to its portfolio of supported self-management programmes, services, publications and digital offerings, called SMILE-RA (Self-Management Individualised Learning Environment in Rheumatoid Arthritis). Rheumatoid Arthritis (>400,000 adults live with RA in the UK) is a serious and complex autoimmune disease characterised […]
News, 31 Aug The OCTAVE study results The OCTAVE study results were released on 24 August 2021 and we realise that the initial headlines could cause concern and worry. The study looked at vaccine response of those who are ‘immuno-compromised’ which includes a very wide range of people at varying levels of immune-compression. What the study has shown is that compared to people […]
News, 27 Jul HCP Only – GRA physician registry: COVID-19 cases after vaccination If you are a healthcare provider Global Rheumatology Alliance physician registry are looking for patient clinical information on patients with COVID-19 after vaccination. The GRA physician registry is now focusing on patients who develop COVID-19 after their vaccination. If you have these patients, GRA would deeply appreciate if you could take a moment to enter their […]
News, 14 Jul Biggest change to treatment of RA since the introduction of biologics in the early 2000s Last month we brought you the news about the Draft Final decision from NICE regarding treatment of ‘moderate active’ RA with some advanced therapies and we’re now delighted to say that as of 14th July this is now Final Guidance. This is an incredible achievement after years of campaigning and has the potential to improve […]
News, 05 Jul NRAS launch the #DoThe20Challenge to celebrate 20 years This challenge has now closed. Thank you to everyone who participated and helped raise funds! To celebrate our 20th Anniversary, we have launched #DoThe20Challenge, a fun way supporters can celebrate with us! There are a lot of ideas to get you started, anything that involves the number 20 – are you ready to take on the challenge? […]
News, 21 Jan NICE offers hope for thousands who until now, potentially faced a life of disability and pain The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected by […]
Stay up to date Sign up for all the latest RA and NRAS news and receive our regular monthly emails on the latest RA research, events and advice. Sign up